Online citations, reference lists, and bibliographies.
← Back to Search

Impact Of Nocturia On Symptom-specific Quality Of Life Among Community-dwelling Adults Aged 40 Years And Older.

Hong-Jeng Yu, Fong-Ying Chen, P. Huang, T. Chen, W. Chie, Cheng-Ying Liu
Published 2006 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES To evaluate factors predicting the effect of nocturia in a community-based cohort of adults using a nocturia-specific quality-of-life (N-QOL) questionnaire. METHODS From October 2004 to February 2005, adults aged 40 years old or older living in Matsu, Taiwan and reporting nocturia of one episode or more per night were interviewed with a 12-item N-QOL questionnaire consisting of Sleep/Energy and Bother/Concern subscales. Univariate analyses were used to analyze the effects of demographic characteristics, frequency and duration of nocturia, and sleeping characteristics on the N-QOL score. Multiple linear regression analysis was used to identify factors predicting the N-QOL score. RESULTS A total of 663 adults completed this study (mean age 59.4 years). The average N-QOL scores (a lower score indicates worse QOL) were 91.4 +/- 11.2, 83.7 +/- 13.2, 77.6 +/- 16.8, and 67.6 +/- 21.2 for nocturia episodes of 1, 2, 3, and 4 or more per night, respectively (P < 0.001). Men reported significantly lower N-QOL (85.6 +/- 15.1 versus 88.9 +/- 13.1, P = 0.003) and Bother/Concern subscale scores (42.0 +/- 8.4 versus 44.0 +/- 7.4, P < 0.001), but not Energy/Sleep subscale scores (43.6 +/- 7.8 versus 44.4 +/- 7.3, P = 0.158) than women. On multiple linear regression analysis, increasing nocturia episodes (regression coefficient -6.2, 95% confidence interval -7.4 to -5.0), male sex (regression coefficient -3.5, 95% confidence interval -5.4 to -1.5), and degree of sleeping disturbance after nocturia (regression coefficient -4.5, 95% confidence interval -5.6 to -3.4) independently predicted a significantly lower N-QOL score. CONCLUSIONS The results of our study have confirmed that nocturia has a more significant QOL impact when the patient has two or more episodes per night. Moreover, men experienced a greater impact from nocturia than women, particularly in the Bother/Concern domain.
This paper references
rinary symptoms and incontinence in women: relationships 717 b 4 l a 9 C b 1 c 1 s S r v 7 etween occurrence, age, and perceived impact
LV Swithinbank (1999)
10.1023/A:1023250632395
Quality of life impact and treatment seeking of Chinese women with urinary incontinence
Hong-Jeng Yu (2004)
Prevalence and assoiated factors of nocturia among adult residents of the Matsu rea of Taiwan
HJ Yu (2005)
Cross - sec - ional study of nocturia in both sexes : analysis of a voluntary ealth screening project
G Schatzl (2000)
Productivity, itality and utility in a group of healthy professionally active ndividuals with nocturia
G Kobelt (2003)
10.29828/JFMA.200506.0012
Prevalence and associated factors of nocturia among adult residents of the Matsu area of Taiwan.
Hong-Jeng Yu (2005)
10.1046/j.1464-410X.84.s1.2.x
Measuring the impact of nocturia on quality of life
J. Donovan (1999)
10.1016/S0090-4295(00)00603-8
Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project.
G. Schatzl (2000)
10.1002/NAU.10053
The standardisation of terminology in nocturia: Report from the standardisation sub‐committee of the International Continence Society
P. V. van Kerrebroeck (2002)
10.1016/S0022-5347(05)67961-X
CLINICAL UROLOGY: Review ArticleNOCTURIA
J. P. Weiss (2000)
10.1080/003655999750016050
Lower urinary tract symptoms--a population survey using the Danish Prostatic Symptom Score (DAN-PSS) questionnaire.
Lynn Kay (1999)
Nocturia : a risk actor for falls in the elderly
RB Stewart
10.1046/j.1464-410X.2003.04062.x
Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia
G. Kobelt (2003)
Cross-secional study of nocturia in both sexes: analysis of a voluntary ealth screening
G Schatzl (2000)
10.1046/j.1464-410X.90.s3.3.x
The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society
P. V. van Kerrebroeck (2002)
10.1016/S0378-5122(00)00111-0
Nocturia and health in women aged 40-64 years.
R. Asplund (2000)
Nocturia and health in omen aged 40–64
R Asplund (2000)
10.1016/J.UROLOGY.2003.10.019
Development and validation of a quality-of-life measure for men with nocturia.
L. Abraham (2004)
The tandardization of terminology in nocturia: report from the tandardization Subcommittee of the International Contience Society
P Van Kerrebroeck (2002)
10.1111/j.1532-5415.1992.tb03645.x
Nocturia: A Risk Factor for Falls in the Elderly
R. B. Stewart (1992)
10.1111/j.1464-410X.2003.04527.x
The prevalence of nocturia and its effect on health‐related quality of life and sleep in a community sample in the USA
K. Coyne (2003)
10.1016/S0022-5347(01)65075-4
The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms.
T. Peters (1997)
Degree of bother aused by nocturia in women
J Fiske (2004)
Urinary symptoms and incontinence in women: relationships between occurrence, age, and perceived impact.
L. Swithinbank (1999)
10.1093/GERONA/51A.3.M108
Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep.
H. Middelkoop (1996)
Developent and validation of a quality-of-life measure for men with octuria
L Abraham (2004)
The International ontinence Society “ Benign Prostatic Hyperplasia ” study : the othersomeness of urinary symptoms
TJ Peters
10.1002/NAU.20022
Degree of bother caused by nocturia in women
J. Fiske (2004)



This paper is referenced by
10.1002/nau.22365
Nocturia and overnight polysomnography in Parkinson disease
C. Vaughan (2013)
10.1002/nau.22219
Nocturia think tank: Focus on nocturnal polyuria: ICI‐RS 2011
J. Weiss (2012)
10.1111/j.1464-410X.2010.09763.x
Nocturia as a manifestation of systemic disease
D. Gulur (2011)
10.1111/iju.13877
Efficacy of novel β3‐adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post‐hoc analysis of a randomized, double‐blind, placebo‐controlled phase 3 study
Masaki Yoshida (2019)
10.1016/j.sleep.2013.08.791
Sleep disorders in multiple sclerosis and their relationship to fatigue.
C. Veauthier (2014)
10.1093/gerona/gln009
Correlates of self-reported nocturia among community-dwelling older adults.
Y. Endeshaw (2009)
10.1007/978-1-4614-1156-7_5
Epidemiology of Nocturia: Evaluation of Prevalence, Incidence, Impact and Risk Factors
Kari A.O. Tikkinen (2012)
10.1016/j.juro.2010.05.093
Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study.
H. Nakagawa (2010)
[Impact of nocturia on the daily life of patients with lower urinary tract symptoms due to benign prostatic hyperplasia].
J. Cornu (2007)
10.1111/j.1742-1241.2011.02868.x
Self‐rated sleep characteristics and bother from nocturia
C. Vaughan (2012)
10.1097/OGX.0b013e3181ecde66
Nocturia
K. Ashok (2010)
10.1371/journal.pone.0169690
Nocturia Is Associated with Slipping and Falling
S. Kim (2017)
10.3109/21681805.2012.762038
Relationship between endothelial dysfunction and nocturia with benign prostatic hyperplasia
M. Inci (2013)
10.1007/978-1-4614-1156-7_3
Nocturia and Sleep Disorders
S. Ancoli-Israel (2012)
10.4111/KJU.2008.49.10.899
Study on Persistent Nocturia after Treatment of Benign Prostatic Hyperplasia and Effectiveness of Desmopressin in Persistent Nocturia with Nocturnal Polyuria
Jae Young Jong (2008)
10.1590/S0080-62342011000500011
[Factors associated to sleep pattern in heart failure patients].
M. D. dos Santos (2011)
10.1007/s11934-013-0368-z
Promising Molecular Targets and Biomarkers for Male BPH and LUTS
Mehrnaz Gharaee-Kermani (2013)
10.1111/luts.12347
Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long‐term, multicenter phase 3 study of desmopressin in Japanese patients
K. V. Juul (2020)
10.4111/kju.2010.51.9.631
Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study
G. Hong (2010)
10.1016/j.eururo.2007.12.029
Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity.
V. Kalsi (2008)
10.1002/NAU.20451
Differences between bothersome and non‐bothersome night‐time frequency
K. Yoshimura (2007)
10.1007/S11884-011-0105-8
Evaluation and Management of Nocturia in Older Men
M. Harel (2011)
10.1111/j.1742-1241.2010.02336.x
Thinking beyond the bladder: antidiuretic treatment of nocturia
P. V. van Kerrebroeck (2010)
10.1007/978-1-84628-831-9_2
The Pathophysiology of Overactive Bladder
A. Wein (2012)
10.1016/j.juro.2011.05.083
Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia.
J. Weiss (2011)
10.1155/2018/4721505
What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT
Rafiyah Khan (2018)
10.1002/nau.22593
The economic impact of nocturia
T. Holm-Larsen (2014)
10.1016/j.jsmc.2017.09.010
Sleep and Nocturia in Older Adults.
C. Vaughan (2018)
10.1016/J.UROLOGY.2013.12.060
Re: Can Treatment of Nocturia Increase Testosterone Level in Men with Late Onset Hypogonadism?
T. Griebling (2014)
10.1007/s00192-011-1525-x
Nocturia × disturbed sleep: a review
D. Furtado (2011)
10.3109/21681805.2014.973901
Determinants of nocturia severity in men, derived from frequency–volume charts
Svetlana Avulova (2015)
10.1002/nau.21125
Nocturia: New Directions
J. Weiss (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar